Expanding it to all children whose height was below the third percentile would create 90,000 new customers and US $10 billion in revenue .
Limiting sales of the hormone to children diagnosed with growth hormone deficiency , rather than being short for any reason , limited their sales market .
Expanding it to all children whose height was below the third percentile would create 90,000 new customers and US $10 billion in revenue .
Limiting sales of the hormone to children diagnosed with growth hormone deficiency , rather than being short for any reason , limited their sales market .